Recombinant growth hormone: a new cardiovascular drug therapy (Q41272674)

29 September 2017

1 reference

title

Recombinant growth hormone: a new cardiovascular drug therapy (English)

1 reference

29 September 2017

Gomberg-Maitland M

1

1 reference

29 September 2017

Frishman WH

series ordinal

2

1 reference

29 September 2017

language of work or name

English

0 references

publication date

1 December 1996

1 reference

29 September 2017

published in

American Heart Journal

1 reference

29 September 2017

volume

132

1 reference

29 September 2017

issue

6

1 reference

29 September 2017

page(s)

1244-1262

1 reference

III. Partial Hypophysectomy for Acromegaly: With Remarks on the Function of the Hypophysis

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

THE ISOLATION OF PITUITARY GROWTH HORMONE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Preparation and properties of growth hormone from human and monkey pituitary glands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Treatment of a pituitary dwarf with human growth hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Creutzfeldt-Jakob disease after administration of human growth hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Direct expression in Escherichia coli of a DNA sequence coding for human growth hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophysial-portal circulation of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Role of central dopaminergic pathways in the neural control of growth hormone secretion in normal men: studies with metoclopramide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Human hypothalamic growth hormone releasing factor (GRF): evidence for two forms identical to tumor derived GRF-44-NH2 and GRF-40.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Growth hormone secretagogues. Clinical experience and therapeutic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Evaluation of growth hormone secretion and treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Growth, growth hormone and the somatomedins: a historical perspective and current concepts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Growth hormone receptor and serum binding protein: purification, cloning and expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

On the actions of the growth hormone-releasing hexapeptide, GHRP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Growth hormone (GH) receptors, GH binding protein and GH: an autoregulatory system?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Circadian variation of basal plasma growth hormone in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Growth hormone, exercise, and aging: the future of therapy for the frail elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Neuroendocrine regulation of growth hormone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Intersubject viability in growth hormone time course during different types of work

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Growth hormone, body composition, and aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Somatomedin-C levels in healthy young and old men: relationship to peak and 24-hour integrated levels of growth hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Somatomedin: Proposed Designation for Sulphation Factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Primary structure of human insulin-like growth factor II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Localization of insulin-like growth factor genes to human chromosomes 11 and 12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Insulin-like growth factors and their binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone an

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Effects of aging and sex on plasma insulin-like growth factor I (IGF-I) levels in normal adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Influence of physical activity on insulin-like growth factor-I in healthy younger and older men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Role of Growth Hormone in Fluid Homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Expansion of extracellular volume and suppression of atrial natriuretic peptide after growth hormone administration in normal man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Growth hormone administration and carbohydrate metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Growth hormone and lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Growth hormone and protein metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

7 January 2021

Growth Hormone and Bone

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

The acute effects of human growth hormone administration on thyroid function in normal men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Immunological findings in growth hormone-treated patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Insulin-like growth factors and insulin increase the contractility of neonatal rat cardiocytes in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Induction of myocardial insulin-like growth factor-I gene expression in left ventricular hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Exogenously administered growth hormone and insulin-like growth factor-I alter intracellular Ca2+ handling and enhance cardiac performance. In vitro evaluation in the isolated isovolumic buffer-perfused rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Growth hormone and the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Acromegaly and the heart: a clinical and pathologic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Acromegaly and cardiovascular disorders. A prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Evidence for biventricular involvement in acromegaly: a Doppler echocardiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

The restoration of cardiac hypertrophy and blood pressure in hypophysectomized rats by large doses of lyophilized anterior pituitary and growth hormone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Effect of excessive secretion of growth hormone on tissues of the rat, with particular reference to the heart and skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Cardiomegaly and haemodynamics in rats with a transplantable growth hormone-secreting tumour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Mechanical properties of rat cardiac skinned fibers are altered by chronic growth hormone hypersecretion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Wall stress and patterns of hypertrophy in the human left ventricle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Adaptations of the left ventricle to chronic pressure overload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

A hyperkinetic heart in uncomplicated active acromegaly. Explanation of hypertension in acromegalic patients?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Rapid reduction of left ventricular hypertrophy in acromegaly after suppression of growth hormone hypersecretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Premature mortality due to cardiovascular disease in hypopituitarism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Cardiovascular risk factors in adult patients with growth hormone deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Cardiovascular and renal effects of growth hormone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Trophic factor supplementation: effect on the age-associated changes in body composition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Improved left ventricular function after growth hormone replacement in patients with hypopituitarism: assessment with radionuclide angiography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Cardiovascular effects of growth hormone replacement therapy in hypopituitary adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Beneficial effects of growth hormone treatment in GH-deficient adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Clinical aspects of growth hormone deficiency in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Adrenoceptor-mediated cardiac and vascular responses in genetically growth hormone-deficient rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Fibrinogen as a risk factor for stroke and myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Studies of hyperlipidemia in the HGH-deficient state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Adipose tissue assessed by magnetic resonance imaging in growth hormone-deficient adults: the effect of growth hormone replacement and a comparison with control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Serum lipid levels in growth hormone-deficient men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Reversible dilated cardiomyopathy due to growth hormone deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Cardiac failure responding to growth hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Dose-response studies with biosynthetic human growth hormone (GH) in GH-deficient patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Cardiovascular effects of growth hormone treatment in growth-hormone-deficient adults: stimulation of the renin-aldosterone system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Effects of growth hormone substitution on mental performance in adults with growth hormone deficiency: a pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Clinical actions of growth hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Does growth hormone increase the risk of malignancies?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

A Preliminary Study of Growth Hormone in the Treatment of Dilated Cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Impaired spontaneous growth hormone secretion in severe dialated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Growth Hormone Improves Cardiac Performance in Experimental Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats treated with chronic ACE inhibition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Complicated acute myocardial infarction. Heart failure, shock, mechanical complications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Preservation of the myocardial collagen framework by human growth hormone in experimental infarctions and reduction in the incidence of ventricular aneurysms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Bivalent effects of human growth hormone in experimental myocardial infarcts. Protective when administered alone and aggravating when combined with beta blockers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Effects of human growth hormone in men over 60 years old

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Effects of short term administration of recombinant human growth hormone to elderly people

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Growth hormone replacement in healthy older men improves body composition but not functional ability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

The use of growth hormone in adults: a changing scene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Potential therapeutic applications of growth hormone in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Repetitive growth hormone-releasing hormone administration restores the attenuated growth hormone (GH) response to GH-releasing hormone testing in normal aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Effect of 15-day treatment with growth-hormone-releasing hormone alone or combined with different doses of arginine on the reduced somatotrope responsiveness to the neurohormone in normal aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990469-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-8703(96)90469-X

1 reference

29 September 2017

1 reference